Nasdaq
DNLI
Denali Therapeutics Inc.
- Health Care
- Listed 2017
- 1 day
- +1.3%
- 1 month
- −6.0%
- 1 year
- +72.3%
$24.73 · Mkt cap $3.92B
At the 6 Aug 2026 close
Nasdaq
Denali Therapeutics Inc.
$24.73 · Mkt cap $3.92B
At the 6 Aug 2026 close
Denali Therapeutics Inc. trades under the ticker DNLI on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2017. Its market capitalisation is $3.92B. The last closing price was $24.73, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +72.3%, and −6.0% over the past month. Returns are price returns and exclude dividends.
This page exists because DNLI is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.